The estimated Net Worth of Maureen T. F. Reitman is at least $7.43 Milion dollars as of 13 March 2024. Dr Reitman owns over 6,206 units of Exponent stock worth over $3,653,852 and over the last 5 years he sold EXPO stock worth over $2,957,764. In addition, he makes $818,971 as Corp. VP - Polymers Science & Materials Chemistry a Principal Engineer and Practice Director at Exponent.
Dr has made over 12 trades of the Exponent stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 6,206 units of EXPO stock worth $649,086 on 13 March 2024.
The largest trade he's ever made was exercising 10,224 units of Exponent stock on 10 March 2021 worth over $1,069,328. On average, Dr trades about 4,283 units every 86 days since 2020. As of 13 March 2024 he still owns at least 34,935 units of Exponent stock.
You can see the complete history of Dr Reitman stock trades at the bottom of the page.
Dr. Maureen T. F. Reitman Sc.D., F.S.P.E., P.E. is the Corp. VP - Polymers Science & Materials Chemistry, Principal Engineer and Practice Director at Exponent.
As the Corp. VP - Polymers Science & Materials Chemistry a Principal Engineer and Practice Director of Exponent, the total compensation of Dr E at Exponent is $818,971. There are 7 executives at Exponent getting paid more, with Catherine Corrigan having the highest compensation of $2,607,550.
Dr E is 52, he's been the Corp. VP - Polymers Science & Materials Chemistry a Principal Engineer and Practice Director of Exponent since . There are 18 older and 5 younger executives at Exponent. The oldest executive at Exponent Inc. is Dr. Subbaiah V. Malladi, 74, who is the CTO & Principal Engineer.
Over the last 21 years, insiders at Exponent have traded over $73,571,565 worth of Exponent stock and bought 2,000 units worth $170,360 . The most active insiders traders include Paul R Johnston, Richard L Jr Schlenker a John B Shoven. On average, Exponent executives and independent directors trade stock every 11 days with the average trade being worth of $675,547. The most recent stock trade was executed by Richard L Jr Schlenker on 31 July 2024, trading 40,662 units of EXPO stock currently worth $4,339,042.
exponent is an engineering and scientific consulting firm providing solutions to complex problems. whether the firm investigates an incident that happened in the past, or assists with the development of a new product or service, exponent offers knowledge to assist its clients make informed, intelligent decisions. exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and business today. the firm's consultants analyze failures and accidents to determine their causes and provide answers to help prevent such problems. in addition, exponent evaluates human health and environmental concerns to find cost-effective solutions. exponent’s staff of approximately 900, located in 20 offices throughout the nation and 6 international offices, combines unparalleled technical expertise with the ability, when necessary, to focus this knowledge in extreme
Exponent executives and other stock owners filed with the SEC include: